< Back to previous page
Researcher
Hans Wildiers
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2005 → Today
Projects
1 - 10 of 22
- Building a large blood biobank of patients with new breast cancer diagnosis for future researchFrom1 Jan 2022 → TodayFunding: Other federal public and semi-governmental institutions
- UPTIDER (UZ/KU Leuven Program for post-mortem Tissue Donation to Enhance Research), a unique setting to unravel treatment resistance and disease progression in patients with breast cancer.From1 Oct 2021 → TodayFunding: BOF - projects
- The impact of coaching on quality of life of older cancer patientsFrom27 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Streamlined Geriatric and Oncological evaluation based on IC Technology for holistic patient-oriented healthcare management for older multimorbid patientsFrom1 Apr 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- Mechanisms involved in metastasis of luminal breast cancerFrom1 Mar 2021 → 28 Feb 2022Funding: Foundations, funds and other with scientific goal
- The MBC biobank collection.From1 Dec 2020 → 31 Oct 2021Funding: Other federal public and semi-governmental institutions
- Novel biomarkers in the risk stratification, surveillance and treatment of young breast cancer patients and germline carriers of pathogenic variants in TP53.From1 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of lipid metabolism in metastasis formationFrom13 Jan 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Linking patient adiposity to tumour microenvironment and therapy response in breast cancer: towards tailored treatment strategies in obesityFrom27 Sep 2019 → TodayFunding: Foundations, funds and other with scientific goal, FWO Strategic Basic Research Grant
- Hormone-sensitive breast cancer: Tumor biology, prognostic/predictive biomarkers and specific treatment approachesFrom1 Sep 2019 → TodayFunding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 367
- Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of exploratory analyses from the phase III BROCADE3 trial.(2022)
Authors: Hans Wildiers
Pages: 299 - 309 - Genomics of metastatic breast cancer(2022)
Authors: Tatjana Geukens, Maxim De Schepper, François Richard, Sophia Leduc, Edoardo Isnaldi, Wouter Van Den Bogaert, Kevin Punie, Patrick Neven, Hans Wildiers, Christine Desmedt
Pages: 18 - 28 - The role of vitamin D in breast cancer risk and progression(2022)
Authors: Justine Vanhevel, Lieve Verlinden, Stefanie Doms, Hans Wildiers, Annemieke Verstuyf
Pages: R33 - R55 - Pushing the boundaries. Concurrent Hodgkin lymphoma and breast cancer treatment with preservation of pregnancy: A case report(2022)
Authors: Charlotte Lejeune, Daan Dierickx, Hans Wildiers, Lore Lannoo, Kristel Van Calsteren, Joris Vermeesch, Frédéric Amant
Number of pages: 5 - Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer(2022)
Authors: Annouschka Laenen, Patrick Neven, Kevin Punie, Hans Wildiers
Pages: 293 - 301Number of pages: 9 - CANCER IN OLDER PERSONS - IMPACT OF AGE ON TUMOR BIOLOGY AND IMMUNE RESPONSE(2021)
Authors: Lieze Berben, Hans Wildiers, Sigrid Hatse, Giuseppe Floris
- Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global survey.(2021)
Authors: Hans Wildiers
Pages: 100219 - The value of population-based databases to evaluate long-term patient outcomes: A multicentric research project in older patients with cancer(2021)
Authors: Cindy Kenis, Hans Wildiers
Pages: 362 - 366 - Biomarker Analysis of the Phase III NALA Study of Neratinib plus Capecitabine versus Lapatinib plus Capecitabine in Patients with Previously Treated Metastatic Breast Cancer(2021)
Authors: Hans Wildiers
Pages: 5818 - 5827Number of pages: 10 - Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative(2021)
Authors: Hans Wildiers
Pages: 2796 - 2811Number of pages: 16